Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Share-based Compensation (2016 - 2025)

Veracyte (VCYT) has disclosed Share-based Compensation for 12 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 13.21% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.6 million through Dec 2025, up 20.28% year-over-year, with the annual reading at $43.6 million for FY2025, 20.28% up from the prior year.
  • Share-based Compensation hit $10.9 million in Q4 2025 for Veracyte, up from $10.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $11.0 million in Q2 2025 to a low of $3.9 million in Q1 2021.
  • Historically, Share-based Compensation has averaged $8.1 million across 5 years, with a median of $7.9 million in 2021.
  • Biggest five-year swings in Share-based Compensation: soared 154.71% in 2021 and later decreased 7.44% in 2022.
  • Year by year, Share-based Compensation stood at $6.7 million in 2021, then rose by 2.01% to $6.9 million in 2022, then grew by 9.39% to $7.5 million in 2023, then rose by 28.18% to $9.6 million in 2024, then grew by 13.21% to $10.9 million in 2025.
  • Business Quant data shows Share-based Compensation for VCYT at $10.9 million in Q4 2025, $10.8 million in Q3 2025, and $11.0 million in Q2 2025.